Femoral plaques confound the association of circulating oxidized low-density lipoprotein with carotid atherosclerosis in a general population aged 35 to 55 years the Asklepios study

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 28, Issue 8, 2008, Pages 1563-1568

  Langlois, Michel R ^a   Rietzschel, Ernst R ^b   De Buyzere, Marc L ^b   De Bacquer, Dirk ^c   Bekaert, Sofie ^c   Blaton, Victor ^a   De Backer, Guy G ^c   Gillebert, Thierry C ^b  

^a General Hospital St Jan   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c GHENT UNIVERSITY   (Belgium)

Author keywords

Atherosclerosis; Carotid arteries; Doppler ultrasound; Oxidized lipids; Peripheral vasculature

Indexed keywords

OXIDIZED LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD ANALYSIS; CARDIOVASCULAR RISK; CAROTID ARTERY; CAROTID ARTERY DISEASE; CONTROLLED STUDY; DOPPLER FLOWMETRY; FEMALE; FEMORAL ARTERY; HUMAN; LIFESTYLE; LIPOPROTEIN BLOOD LEVEL; MALE; NORMAL HUMAN; PRIORITY JOURNAL; STRUCTURED QUESTIONNAIRE; BLOOD; CROSS-SECTIONAL STUDY; ECHOGRAPHY; INTIMA; MIDDLE AGED; PATHOLOGY;

ADULT; ATHEROSCLEROSIS; CAROTID ARTERY DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; FEMORAL ARTERY; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; TUNICA INTIMA;

EID: 52449129346     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.108.167346     Document Type: Article

References (34)

1. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999; 340:115-126.
2. Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem. 1997;272:20963-20966.
3. Holvoet P, Stassen JM, Van Cleemput J, Collen D, Vanhaecke J. Oxidized low density lipoproteins in patients with transplant-associated coronary artery disease. Arterioscler Thromb Vasc Biol. 1998;18: 100-107.
4. Toshima S, Hasegawa A, Kurabayashi M, Itabe H, Takano T, Sugano J, Shimamura K, Kimura J, Michishita I, Suzuki T, Nagai R. Circulating oxidized low density lipoprotein levels: a biochemical risk marker for coronary heart disease. Arterioscler Thromb Vasc Biol. 2000;20:2243-2247.
5. Holvoet P, Vanhaecke J, Janssens S, Van de Werf F, Collen D. Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation. 1998;98: 1487-1494.
6. Holvoet P, Mertens A, Verhamme P, Bogaerts K, Beyens G, Verhaeghe R1 Collen D, Muls E, Van de Werf F. Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease. Arterioscler Thromb Vasc Biol. 2001;21:844-848.
7. Ehara S, Ueda M, Naruko T, Haze K, Itoh A, Otsuka M, Komatsu R, Matsuo T, Itabe H, Takano T, Tsukamoto Y, Yoshiyama M, Takeuchi K, Yoshikawa J, Becker AE. Elevated levels of oxidized low-density lipoprotein shows a positive relationship with the severity of acute coronary syndromes. Circulation. 2001;103:1955-1960.
8. Meisinger C, Baumert J, Khuseyinova N, Loewel H, Koenig W. Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population. Circulation. 2005;112:651-657. 9. Wu T, Willett WC, Rifai N, Shai I, Manson JE, Rimm EB. Is plasma oxidized low-density lipoprotein, measured with the widely used antibody 4E6, an independent predictor of coronary heart disease among US men and women? J Am Coll Cardiol. 2006;48:973-979.
9. Hulthe J, Fagerberg B. Circulating oxidized LDL is associated with subclinical atherosclerosis development and inflammatory cytokines (AIR Study). Arterioscler Thromb Vasc Biol. 2002;22:1162-1167.
10. Holvoet P, Jenny NS, Schreiner PJ, Tracy RP, Jacobs DR. The relationship between oxidized LDL and other cardiovascular risk factors and subclinical CVD in different ethnic groups: the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis. 2007;194:245-252.
11. Liu M-L, Ylitalo K, Salonen R, Salonen JT, Taskinen M-R. Circulating oxidized low-density lipoprotein and its association with carotid intima-media thickness in asymptomatic members of familial combined hyperlipidemia families. Arterioscler Thromb Vasc Biol. 2004;24: 1492-1497.
12. Tanaga K, Bujo H, Inoue M, Mikami K, Kotani K, Takahashi K, Kanno T, Saito Y. Increased circulating malondialdehyde-modified LDL levels in patients with coronary artery diseases and their association with peak sizes of LDL particles. Arterioscler Thromb Vasc Biol. 2002;22:662-666.
13. Wallenfeldt K, Fagerberg B, Wikstrand J, Hulthe J. Oxidized low-density lipoprotein in plasma is a prognostic marker of subclinical atherosclerosis development in clinically healthy men. J Intern Med. 2004;556:413-420.
14. Sigurdadottir V, Fagerberg B, Wikstrand J, Schmidt C, Hulthe J. Circulating oxidized low-density lipoprotein is associated with echolucent plaques in the femoral artery independently of hsCRP in 61-year-old men. Atherosclerosis. 2007;190:187-193.
15. Kampus P, Kals J, Ristimäe T, Muda P, Ulst K, Zilmer K, Salonen RM, Tuomainen TP, Teesalu R, Zilmer M. Augmentation index and carotid intima-media thickness are differently related to age, C-reactive protein and oxidized low-density lipoprotein. J Hypertens. 2007;25:819-825.
16. Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a "set up" for vascular disease. Circulation. 2003;107:139-146.
17. Dalager S, Paaske WP, Kristensen IB, Laurberg JM, Falk E. Artery-related differences in atherosclerotic expression. Implications for atherogenesis and dynamics in intima-media thickness. Stroke. 2007;38:2698-2705.
18. Kannel WB. Risk factors for atherosclerotic cardiovascular outcomes in different arterial territories. J Cardiovasc Risk. 1994;1:333-339.
19. van der Meer IM, Iglesias del Sol A, Hak E, Bots ML, Hofman A. Witteman JCM. Risk factors for progression of atherosclerosis measured at multiple sites in the arterial tree. The Rotterdam Study. Stroke. 2003; 34:2374-2379.
20. Bots ML, de Jong PT, Hofman A, Grobbee DE. Left, right, near or far wall common carotid intima-media thickness measurements: associations with cardiovascular disease and lower extremity arterial atherosclerosis. J Clin Epidemiol. 1997;50:801-807.
21. Rietzsehel ER, De Buyzere ML, Bekaert S, Segers P, De Bacquer D, Cooman L, Van Damme P, Cassiman P, Langlois M, Van Oostveldt P. Verdonck P, De Backer G, Gillebert TC. Rationale, design, methods and baseline characteristics of the Asklepios Study. Eur J Cardiovasc Prev Rehabil. 2007;14:179-191.
22. Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, Csiba L, Desvarieux M, Ebrahirn S, Fatar M, Hemandez HR. Jaff M, Kownator S, Prati P, Rundek T, Sitzer M, Schminke U, Tardif JC, Taylor A, Vicaut E, Woo KS, Zannad F, Zureik M. Mannheim carotid intima-media thickness consensus (2004-2006), Cerebrovasc Dis. 2007;23:75-80.
23. Wendelhag I, Wiklund O, Wikstrand J. On quantifying plaque size and intima-media thickness in carotid and femoral arteries: comments on results from a prospective ultrasound study in patients with familial hypercholesterolemia. Arterioscler Thromb Vasc Biol. 1996; 16:843-850.
24. Vermeersch SJ, Rietzsehel ER, De Buyzere ML, Van Bortel LM. D'Asseler Y, Gillebert TC, Verdonck PR, Segers P. Validation of a new automated IMT measurement algorithm. J Hum Hypertens. 2007;21:976-978.
25. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-501.
26. Brouwers A, Langlois M, Delanghe J, Billiet J, De Buyzere M, Vercaemst R, Rietzsehel E, Bernard D, Blaton V. Oxidized low-density lipoprotein, iron stores, and haptoglobin polymorphism. Atherosclerosis. 2004;176:189-195.
27. Cote C, Pibarot P, Despres JP, Mohty D, Cartier A, Arsenault B, Couture C, Mathieu P. Association between circulating oxidized low-density lipoprotein and fibro-calcific remodeling of the aortic valve in aortic stenosis. Heart. In press.
28. Dalager S, Falk E, Kristensen IB, Paaske WP. Plaque in superficial femoral arteries indicates generalized atherosclerosis and vulnerability to coronary death: an autopsy study. J Vasc Surg. 2008;47:296-302.
29. Langlois M, Duprez D, Delanghe J, De Buyzere M, Clement DL. Vitamin C status is low in peripheral arterial disease and is associated with inflammation and severity of atherosclerosis. Circulation. 2001;103: 1863-1868.
30. Sigurdadottir V, Fagerberg B, Hulthe J. Circulating oxidized low-density lipoprotein (LDL) is associated with risk factors of the metabolic syndrome and LDL size in clinically healthy 58-year-old men (AIR Study). J Intern Med. 2002;252:440-447.
31. Liu M-L, Ylitalo K, Nuotio I, Salonen R, Salonen JT, Taskinen M-R. Association between carotid intima-media thickness and low-density lipoprotein size and susceptibility of low-density lipoprotein to oxidation in asymptomatic members of familial combined hyperlipidemia families. Stroke. 2002;33:1255-1260.
32. Vaudo G, Marchesi S, Siepi D, Brozetti M, Mannarino MR, Pirro M, Schillaci G, Ciuffetti G, Lupattelli G, Mannarino E. Metabolic syndrome and preclinical atherosclerosis: focus on femoral arteries. Metab Clin Exp. 2007;56:541-546.
33. Simon A, Gariepy J, Chironi G, Megnien J-L, Levenson J. Intima-media thickness: a new tool for diagnosis and treatment of cardiovascular risk. J Hypertens. 2002;20:159-169.
34. Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR, McCann TJ, Browner D. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 1992;326:381-386.